BACKGROUND: The development of non-syndromic congenital heart defects (CHDs) involves a complex interplay of genetics, metabolism, and lifestyle. Previous studies have implicated maternal single nucleotide polymorphisms (SNPs) and altered metabolism in folate-related pathways as CHD risk factors. OBJECTIVE: We sought to discover associations between maternal SNPs and metabolites involved in the homocysteine, folate, and transsulfuration pathways, and determine if these associations differ between CHD cases and controls. DESIGN: Genetic, metabolic, demographic, and lifestyle information was available for 335 mothers with CHD-affected pregnancies and 263 mothers with unaffected pregnancies. Analysis was conducted on 1160 SNPs, 13 plasma metabolites, and 2 metabolite ratios. A two-stage multiple linear regression was fitted to each combination of SNP and metabolite/ratio. RESULTS: We identified 4 SNPs in the methionine adenosyltransferase II alpha (MAT2A) gene that were associated with methionine levels. Three SNPs in tRNA aspartic acid methyltransferase 1 (TRDMT1) gene were associated with total plasma folate levels. Glutamylcysteine (GluCys) levels were associated with multiple SNPs within the glutathione peroxidase 6 (GPX6) and O-6-methylguanine-DNA methyltransferase (MGMT) genes. The regression model revealed interactions between genotype and case-control status in the association of total plasma folate, total glutathione (GSH), and free GSH, to SNPs within the MGMT, 5,10-methenyltetrahydrofolate synthetase (MTHFS), and catalase (CAT) genes, respectively. CONCLUSIONS: Our study provides further evidence that genetic variation within folate-related pathways accounts for inter-individual variability in key metabolites. We identified specific SNP-metabolite relationships that differed in mothers with CHD-affected pregnancies, compared to controls. Our results underscore the importance of multifactorial studies to define maternal CHD risk.
BACKGROUND: The development of non-syndromic congenital heart defects (CHDs) involves a complex interplay of genetics, metabolism, and lifestyle. Previous studies have implicated maternal single nucleotide polymorphisms (SNPs) and altered metabolism in folate-related pathways as CHD risk factors. OBJECTIVE: We sought to discover associations between maternal SNPs and metabolites involved in the homocysteine, folate, and transsulfuration pathways, and determine if these associations differ between CHD cases and controls. DESIGN: Genetic, metabolic, demographic, and lifestyle information was available for 335 mothers with CHD-affected pregnancies and 263 mothers with unaffected pregnancies. Analysis was conducted on 1160 SNPs, 13 plasma metabolites, and 2 metabolite ratios. A two-stage multiple linear regression was fitted to each combination of SNP and metabolite/ratio. RESULTS: We identified 4 SNPs in the methionine adenosyltransferase II alpha (MAT2A) gene that were associated with methionine levels. Three SNPs in tRNA aspartic acid methyltransferase 1 (TRDMT1) gene were associated with total plasma folate levels. Glutamylcysteine (GluCys) levels were associated with multiple SNPs within the glutathione peroxidase 6 (GPX6) and O-6-methylguanine-DNA methyltransferase (MGMT) genes. The regression model revealed interactions between genotype and case-control status in the association of total plasma folate, total glutathione (GSH), and free GSH, to SNPs within the MGMT, 5,10-methenyltetrahydrofolate synthetase (MTHFS), and catalase (CAT) genes, respectively. CONCLUSIONS: Our study provides further evidence that genetic variation within folate-related pathways accounts for inter-individual variability in key metabolites. We identified specific SNP-metabolite relationships that differed in mothers with CHD-affected pregnancies, compared to controls. Our results underscore the importance of multifactorial studies to define maternal CHD risk.
Authors: Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset Journal: J Nutr Date: 2006-06 Impact factor: 4.798
Authors: Sonja A Rasmussen; Edward J Lammer; Gary M Shaw; Richard H Finnell; Robert E McGehee; Margaret Gallagher; Paul A Romitti; Jeffrey C Murray Journal: Teratology Date: 2002-10
Authors: Aditi Hazra; Peter Kraft; Ross Lazarus; Constance Chen; Stephen J Chanock; Paul Jacques; Jacob Selhub; David J Hunter Journal: Hum Mol Genet Date: 2009-09-10 Impact factor: 6.150
Authors: Barbara Franke; Sita H H M Vermeulen; Regine P M Steegers-Theunissen; Marieke J Coenen; Mascha M V A P Schijvenaars; Hans Scheffer; Martin den Heijer; Henk J Blom Journal: Birth Defects Res A Clin Mol Teratol Date: 2009-03
Authors: Gary M Shaw; Wei Lu; Huiping Zhu; Wei Yang; Farren B S Briggs; Suzan L Carmichael; Lisa F Barcellos; Edward J Lammer; Richard H Finnell Journal: BMC Med Genet Date: 2009-06-03 Impact factor: 2.103
Authors: Xinyu Tang; Mario A Cleves; Todd G Nick; Ming Li; Stewart L MacLeod; Stephen W Erickson; Jingyun Li; Gary M Shaw; Bridget S Mosley; Charlotte A Hobbs Journal: Am J Med Genet A Date: 2015-04-02 Impact factor: 2.802
Authors: Xinyu Tang; Charlotte A Hobbs; Mario A Cleves; Stephen W Erickson; Stewart L MacLeod; Sadia Malik Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-06-02
Authors: Patrick Y Jay; Ehiole Akhirome; Rachel A Magnan; M Rebecca Zhang; Lillian Kang; Yidan Qin; Nelson Ugwu; Suk Dev Regmi; Julie M Nogee; James M Cheverud Journal: Mol Cell Endocrinol Date: 2016-08-20 Impact factor: 4.102
Authors: Ming Li; Stephen W Erickson; Charlotte A Hobbs; Jingyun Li; Xinyu Tang; Todd G Nick; Stewart L Macleod; Mario A Cleves Journal: Genet Epidemiol Date: 2014-03-02 Impact factor: 2.135
Authors: Wendy N Nembhard; Xinyu Tang; Jingyun Li; Stewart L MacLeod; Joseph Levy; Gerald B Schaefer; Charlotte A Hobbs Journal: Am J Med Genet A Date: 2018-02-05 Impact factor: 2.802
Authors: Ming Li; Jingyun Li; Changshuai Wei; Qing Lu; Xinyu Tang; Stephen W Erickson; Stewart L MacLeod; Charlotte A Hobbs Journal: Ann Hum Genet Date: 2015-11-27 Impact factor: 1.670
Authors: Ming Li; Jingyun Li; Zihuai He; Qing Lu; John S Witte; Stewart L Macleod; Charlotte A Hobbs; Mario A Cleves Journal: Genet Epidemiol Date: 2016-04-07 Impact factor: 2.135
Authors: Ming Li; Mario A Cleves; Himel Mallick; Stephen W Erickson; Xinyu Tang; Todd G Nick; Stewart L Macleod; Charlotte A Hobbs Journal: Hum Genet Date: 2014-06-04 Impact factor: 4.132
Authors: Charlotte A Hobbs; Mario A Cleves; Stewart L Macleod; Stephen W Erickson; Xinyu Tang; Jingyun Li; Ming Li; Todd Nick; Sadia Malik Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-02-18